Sourced of - PANDA - https://rumble.com/v2c785k-march-8-2023.html?mref=umbzp&mrefc=5 Full Title Deep sequencing of the Moderna and Pfizer bivalent vaccines identifies contamination of expression vectors designed for plasmid amplification in bacteria | Kevin McKernan 1 March 2023 | As universities in the United States continue to mandate liability-free injections (COVID vaccines) for students at limited risk of contracting COVID, it becomes imperative that more public information be made available for the ingredients of these experimental vaccines. Both the EMA and the TGA have made note of fragmented RNA and smeary western blots suggesting the vaccine manufacturing process lacks fidelity and transparency. Shortly after the TGA data was released, Patel et al. (Pfizer) published a paper attempting to defuse these concerns. This technical presentation and article at https://anandamide.substack.com/p/curious-kittens investigate this finding. Kevin McKernan is the CSO and Founder of Medicinal Genomics and has pioneered the genomics of cannabis and hemp to build a stronger scientific environment (http://Kannapedia.net) for the study of cannabis based therapeutics and blockchain technologies for tracking and verifying cannabis genetics. Previously, Kevin was the CSO of Courtagen Life Sciences, Inc., and was Vice President and Director of R&D of Life Technologies where he managed the development of Life Technologies next generation SOLiD sequencing technology. Integral to the SOLiD R&D process, Kevin oversaw over 100 research collaborations exploring the new biological frontiers with next generation sequencing and saw particular excitement and traction in human tumor sequencing. Kevin initiated an R&D project to investigate chemFET semiconductor based DNA sequencing and spearheaded a process to acquire the DNA sequencing company Ion Torrent for $350M.